Because both estrogen and androgen are strong modulators of bone remodeling, it is plausible that Greb1 is a target for both further osteoporotic research and a target for the prevention and treatment of postmenopausal osteoporosis. The gene discussed is GREB1; the disease is postmenopausal osteoporosis.